IP Library Assignment 022575/0312
Patent Assignment
Reel/Frame 022575/0312

Re-Record to Correct Property Number on a Document Previously Recorded at Reel 022127, Frame 0451. (Assignment of Assignor's Interest)

Recorded: 2009-04-20 Pages: 10
Assignor
WILEX AG
Executed: 2008-01-18
Assignee
WILEX AG
GRILLPARZERSTRASSE 10, 81675 MUENCHEN, GERMANY
Covered Properties (35)
Meta-Substituted Phenylalanine Derivatives
Patent: 5,518,735 →
Application: 07/910,087 →
Inhibitors for Urokinase Receptor
Patent: 6,872,702 →
Application: 09/402,464 →
Novel Urokinase Inhibitors
Patent: 6,624,169 →
Application: 09/743,800 →
Urokinase Inhibitors
Patent: 7,745,441 →
Application: 09/787,647 →
Diagnostic and Therapeutic Use of Antibodies Against the Urokinase Receptor
Patent: 7,157,238 →
Application: 09/926,323 →
Publication: US 2004/0214245
Cyclic Peptidomimetic Urokinase Receptor Antagonists
Patent: 6,906,032 →
Application: 10/031,401 →
Selective Inhibitors of the Urokinase Plasminogen Activator
Patent: 7,049,460 →
Application: 10/049,634 →
Arginine Mimetics as Factor Xa Inhibitors
Patent: 7,038,074 →
Application: 10/182,706 →
Publication: US 2003/0021773
Novel Urokinase Inhibitors
Patent: 6,680,320 →
Application: 10/202,850 →
Publication: US 2003/0013723
Highly Selective Inhibitors of the Urokinase Plasminogen Activator
Patent: 6,841,702 →
Application: 10/239,074 →
Publication: US 2003/0100584
Urokinase Inhibitors
Patent: 6,861,435 →
Application: 10/472,367 →
Publication: US 2004/0110831
Method for Producing 3-Amidinophenylalanine Derivatives
Patent: 7,211,670 →
Application: 10/506,256 →
Publication: US 2005/0176962
Co-Administration of CG250 and Il-2 or Ifn-Alpha for Treating Cancer Such as Renal Cell Carcinomas
Patent: 7,632,496 →
Application: 10/517,338 →
Publication: US 2005/0261178
Guanidino Phenylalanin Compounds Used as Urokinase Inhibitors
Patent: 7,538,216 →
Application: 10/517,518 →
Publication: US 2005/0267127
Formulation of liposomal derivatives of phenylalanine
Application: 10/521,805 →
Publication: US 2005/0181034
Method for the Production of Phenylalanine Derivatives
Patent: 7,247,724 →
Application: 10/522,218 →
Publication: US 2005/0245757
Method of producing recombinant antibodies
Application: 10/635,908 →
Publication: US 2004/0219633
Methods for the Detection and Prognosis of Breast Tumors
Patent: 7,407,751 →
Application: 10/679,951 →
Publication: US 2004/0197863
Novel Urokinase Inhibitors and Uses Thereof
Patent: 7,342,018 →
Application: 10/691,528 →
Publication: US 2004/0138233
Selective urokinase inhibitors
Application: 10/866,196 →
Publication: US 2004/0266766
Highly Selective Inhibitors of the Urokinase Plasminogen Activator
Patent: 7,049,344 →
Application: 10/992,844 →
Publication: US 2005/0119348
Cyclic Peptidomimetic Urokinase Receptor Antagonists
Patent: 7,045,504 →
Application: 11/018,311 →
Publication: US 2005/0101526
Selective Inhibitors of the Urokinase Plasminogen Activator
Patent: 7,208,521 →
Application: 11/058,699 →
Publication: US 2005/0215642
Hydroxyamidine and Hydroxyguanidine Compounds as Urokinase Inhibitors
Patent: 7,608,623 →
Application: 11/287,480 →
Publication: US 2006/0142305
Cyclic Peptidomimetic Urokinase Receptor Antagonists
Patent: 7,314,863 →
Application: 11/321,534 →
Publication: US 2006/0105943
Arginine mimetics as factor Xa inhibitors
Application: 11/400,374 →
Publication: US 2006/0189689
Method for Preparing and Purifying 3-Hydroxyamidinophenylalanine Compounds
Patent: 7,951,943 →
Application: 11/576,978 →
Publication: US 2008/0039626
Diagnostic and Therapeutic Use of Antibodies Against the Urokinase Receptor
Patent: 7,399,468 →
Application: 11/586,579 →
Publication: US 2007/0066798
Adjuvant Theraphy of G250-Expressing Tumors
Patent: 7,691,375 →
Application: 11/630,170 →
Publication: US 2007/0207157
Stable Dosage Form of Phenylalanine Derivatives
Patent: 9,089,532 →
Application: 11/631,891 →
Publication: US 2007/0244127
Hybridoma cell line G250 and its use for producing monoclonal antibodies
Application: 11/655,110 →
Publication: US 2008/0138275
Crystalline Modifications of N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-Hydroxyamidino- (L)- Phenylalanine 4-Ethoxycarbonylpiperazide and/or Salts Thereof
Patent: 7,713,980 →
Application: 11/664,266 →
Publication: US 2008/0058346
Monoclonal Antibodies Specific for the Chemotactic Epitope of the Urokinase-Type Plasminogen Activator Receptor
Patent: 7,951,589 →
Application: 11/814,093 →
Publication: US 2009/0202550
Hydroxyamidine and Hydroxyguanidine Compounds as Urokinase Inhibitors
Patent: 7,807,681 →
Application: 12/105,975 →
Publication: US 2008/0261998
Nucleic Acids Encoding a Deletion Variant of Upar
Patent: 8,461,321 →
Application: 12/164,881 →
Publication: US 2009/0202504
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 10, 1993
From: STURZEBECHER, JORG; VIEWEG, HELMUT; WIKSTROEM, PETER
To: PENTAPHARM AG
Reel/Frame 006532/0744 →
Assignment of Assignor's Interest Feb 16, 2000
From: KESSLER, HORST; GRAEFF, HEINRICH; SCHMITT, MANFRED; MAGDOLEN, VIKTOR
To: WILEX BIOTECHNOLOGY GMBH
Reel/Frame 010544/0076 →
Assignment of Assignor's Interest Apr 3, 2001
From: WILHELM, OLAF; MAGDOLEN, VIKTOR; STURZEBECKER, JORG; FOEKENS, JOHN
To: WILEX BIOTECHNOLOGY GMBH
Reel/Frame 011724/0704 →
Assignment of Assignor's Interest Sep 28, 2001
From: WIKSTROM, PETER; VIEWEG, HELMUT; STURZEBECHER, JORG
To: PENTAPHARM AG
Reel/Frame 012285/0479 →
Assignment of Assignor's Interest Jan 18, 2002
From: WILHELM, OLAF; KESSLER, HORST; BURGLE, MARKUS; POTTHOFF, NILS
To: WILEX AG
Reel/Frame 012758/0089 →
Change of Name Feb 20, 2002
From: WILEX BIOTECHNOLOGY GMBH
To: WILEX AG
Reel/Frame 012600/0084 →
Assignment of Assignor's Interest Feb 25, 2002
From: MAGDOLEN, VIKTOR; MORODER, LUIS; SPERL, STEFAN; STUERZEBECHER, JOERG
To: WILEX AG
Reel/Frame 012882/0014 →
Assignment of Assignor's Interest Mar 5, 2002
From: SCHMITT, MANFRED; NOACK, FRANK; MAGDOLEN, VIKTOR; GRAEFF, HENNER
To: WILEX AG
Reel/Frame 012882/0931 →
Assignment of Assignor's Interest Aug 7, 2002
From: MORODER, LUIS; SPERL, STEFAN; STURZEBECHER, JORG
To: WILEX AG
Reel/Frame 013319/0022 →
Assignment of Assignor's Interest Sep 20, 2002
From: BODE, WOLFRAM; MORODER, LUIS; HUBER, ROBERT; JACOB, UWE
To: WILEX BIOTECHNOLOGY GMBH; MAX-PLANCK-GESSELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Reel/Frame 013439/0140 →
Assignment of Assignor's Interest Sep 18, 2003
From: ZIEGLER, HUGO
To: PENTAPHARM AG
Reel/Frame 014966/0143 →
Assignment of Assignor's Interest Mar 24, 2004
From: WILHELM, OLAF; MAGDOLEN, VIKTOR; STURZEBECKER, JORG; FOEKENS, JOHN
To: WILEX AG
Reel/Frame 014454/0396 →
Assignment of Assignor's Interest Jul 12, 2004
From: LH BOLHUIS, REINIER; WOHL, THORSTEN; BOTTGER, VOLKER
To: WILEX AG
Reel/Frame 014840/0580 →
Assignment of Assignor's Interest Aug 16, 2004
From: SPERL, STEFAN
To: WILEX AG
Reel/Frame 015062/0277 →
Assignment of Assignor's Interest Sep 13, 2004
From: LUTHER, THOMAS; MAGDOLEN, VIKTOR; SCHMITT, MANFRED; MUHLENWEG, BERND
To: WILEX AG
Reel/Frame 015132/0368 →
Assignment of Assignor's Interest Dec 9, 2004
From: WARNAAR, SVEN OLE; ULLRICH, STEFAN
To: WILEX AG
Reel/Frame 016709/0655 →
Assignment of Assignor's Interest Jan 21, 2005
From: WOSIKOWSKI-BUTERS, KATJA; SCHMALIX, WOLFGANG
To: WILEX AG
Reel/Frame 016483/0634 →
Assignment of Assignor's Interest Feb 15, 2005
From: SPERL, STEFAN
To: WILEX AG
Reel/Frame 015716/0897 →
Assignment of Assignor's Interest Mar 18, 2005
From: ZIEGLER, HUGO; WIKSTROEM, PETER
To: PENTAPHARM AG
Reel/Frame 016488/0251 →
Assignment of Assignor's Interest Nov 14, 2005
From: PENTAPHARM AG
To: WILEX AG
Reel/Frame 017017/0280 →
Assignment of Assignor's Interest Nov 18, 2005
From: PENTAPHARM AG
To: WILEX AG
Reel/Frame 017240/0267 →
Assignment of Assignor's Interest Dec 6, 2005
From: PENTAPHARM AG
To: WILEX AG
Reel/Frame 017294/0117 →
Assignment of Assignor's Interest Mar 2, 2006
From: PENTAPHARM AG
To: WILEX AG
Reel/Frame 017297/0825 →
Change of Name Jan 22, 2007
From: WILEX BIOTECHNOLOGY GMBH
To: WILEX AG
Reel/Frame 018787/0054 →
Assignment of Assignor's Interest Apr 24, 2007
From: WOSIKOWSKI-BUTERS, KATJA; SPERL, STEFAN; SOMMER, JOACHIM
To: WILEX AG
Reel/Frame 019200/0095 →